Cargando…

Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab

Detalles Bibliográficos
Autores principales: Saad, Mysa, Bose, Reetesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630754/
https://www.ncbi.nlm.nih.gov/pubmed/37961078
http://dx.doi.org/10.1016/j.jdcr.2023.09.024
_version_ 1785146035870367744
author Saad, Mysa
Bose, Reetesh
author_facet Saad, Mysa
Bose, Reetesh
author_sort Saad, Mysa
collection PubMed
description
format Online
Article
Text
id pubmed-10630754
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106307542023-11-13 Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab Saad, Mysa Bose, Reetesh JAAD Case Rep Case Report Elsevier 2023-10-04 /pmc/articles/PMC10630754/ /pubmed/37961078 http://dx.doi.org/10.1016/j.jdcr.2023.09.024 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Saad, Mysa
Bose, Reetesh
Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
title Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
title_full Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
title_fullStr Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
title_full_unstemmed Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
title_short Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
title_sort erythrodermic pityriasis rubra pilaris following sars-cov-2 vaccination treated with bimekizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630754/
https://www.ncbi.nlm.nih.gov/pubmed/37961078
http://dx.doi.org/10.1016/j.jdcr.2023.09.024
work_keys_str_mv AT saadmysa erythrodermicpityriasisrubrapilarisfollowingsarscov2vaccinationtreatedwithbimekizumab
AT bosereetesh erythrodermicpityriasisrubrapilarisfollowingsarscov2vaccinationtreatedwithbimekizumab